Article
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
20 Feb 2020
Abstract excerpt
Growing experience with engineered chimeric antigen receptor (CAR)-T cells has revealed some of the challenges associated with developing patient-specific therapy. The promising clinical results obtained with CAR-T therapy nevertheless demonstrate the urgency of advancements to promote and expand its uses. There is indeed a need to devise novel methods to generate potent CARs, and to confer them and track their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
